Is Palvella Therapeutics, Inc. (PVLA) a Buy, Sell, or Hold?
NASDAQ : PVLA
Palvella Therapeutics, Inc. — Institutional Ownership
$142.6 USD
-$0.24 (-0.17%)
- Volume
- 132.4K
- Average Volume
- 267.45K
- Market Capitalization
- $2.05B
- P/E Ratio
- -34.20
- Dividend Yield
- 0.00%
- Price Target
- $220.00
- Year High
- $161.38
- Year Low
- $34.57
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $28.88
Institutional Ownership Summary
Institutional Ownership %
1.06%
Investors Holding
23
change: -167 | last: 190
Increased Positions
12
change: -120 | last: 132
Reduced Positions
4
change: -27 | last: 31
New Positions
5
change: -60 | last: 65
Sold Positions
165
change: 138 | last: 27
Total Calls
-
Total Puts
-
Put-Call Ratio
0.00
change: -26.8143 | last: 0.2681
Total Invested
21.1M
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-07-29 | BlackRock, Inc. | 812.95K | 5.70% |
| 2026-02-17 | First Light Asset Management, LLC | 887.03K | 7.49% |
| 2026-02-17 | BIOTECHNOLOGY VALUE FUND L P | 471.2K | 3.80% |
| 2026-02-13 | Frazier Life Sciences Public Fund, L.P. | 706.36K | 6.00% |
| 2025-11-14 | BIOTECHNOLOGY VALUE FUND L P | 634.31K | 5.40% |
| 2025-11-13 | SUVRETTA CAPITAL MANAGEMENT, LLC | 822.4K | 7.40% |
| 2025-08-14 | Frazier Life Sciences Public Fund, L.P. | 545.5K | 4.90% |
| 2025-08-14 | Samsara BioCapital, L.P. | 339.74K | 3.10% |
| 2025-05-15 | Frazier Life Sciences Public Fund, L.P. | 525.73K | 4.80% |
| 2025-01-08 | Frazier Life Sciences Public Fund, L.P. | 440.58K | 3.90% |
| 2024-08-01 | Daniel Schneeberger | 138.64K | 10.50% |
| 2024-08-01 | ADAR1 Capital Management GP, LLC | 138.64K | 10.50% |
| 2024-08-01 | ADAR1 Capital Management, LLC | 138.64K | 10.50% |
| 2024-08-01 | ADAR1 Capital Management GP, LLC | 138.64K | 10.50% |
| 2024-08-01 | Daniel Schneeberger | 138.64K | 10.50% |
| 2024-08-01 | ADAR1 Capital Management, LLC | 138.64K | 10.50% |
| 2024-05-17 | BVF I GP LLC | 137.59K | 10.40% |
| 2024-05-17 | Biotechnology Value Fund II, L.P. | 107.26K | 8.10% |
| 2024-05-17 | BVF II GP LLC | 107.26K | 8.10% |
| 2024-05-17 | BVF GP Holdings LLC | 244.86K | 18.50% |
| 2024-05-17 | BVF Inc. | 257.62K | 19.50% |
| 2024-05-17 | Mark N. Lampert | 257.62K | 19.50% |
| 2024-05-17 | BVF I GP LLC | 137.59K | 10.40% |
| 2024-05-17 | Biotechnology Value Fund, L.P. | 137.59K | 10.40% |
| 2024-05-17 | Mark N. Lampert | 257.62K | 19.50% |
| 2024-05-17 | BVF Inc. | 257.62K | 19.50% |
| 2024-05-17 | Biotechnology Value Fund, L.P. | 137.59K | 10.40% |
| 2024-05-17 | Biotechnology Value Fund II, L.P. | 107.26K | 8.10% |
| 2024-05-17 | BVF Partners OS Ltd. | 9312.0 | 1.00% |
| 2024-05-17 | BVF Partners L.P. | 257.62K | 19.50% |
| 2024-05-17 | BVF Partners L.P. | 257.62K | 19.50% |
| 2024-05-17 | BVF I GP LLC | 137.59K | 10.40% |
| 2024-05-17 | BVF GP Holdings LLC | 244.86K | 18.50% |
| 2024-05-17 | BVF Partners OS Ltd. | 9312.0 | 1.00% |
| 2024-05-17 | Mark N. Lampert | 257.62K | 19.50% |
| 2024-05-17 | BVF Partners L.P. | 257.62K | 19.50% |
| 2024-05-17 | BVF Partners L.P. | 257.62K | 19.50% |
| 2024-05-17 | Biotechnology Value Trading Fund OS LP | 9312.0 | 1.00% |
| 2024-05-17 | BVF Partners OS Ltd. | 9312.0 | 1.00% |
| 2024-05-17 | BVF II GP LLC | 107.26K | 8.10% |
| 2024-05-17 | Biotechnology Value Fund II, L.P. | 107.26K | 8.10% |
| 2024-05-17 | Biotechnology Value Fund II, L.P. | 107.26K | 8.10% |
| 2024-05-17 | BVF I GP LLC | 137.59K | 10.40% |
| 2024-05-17 | Biotechnology Value Fund, L.P. | 137.59K | 10.40% |
| 2024-05-17 | Biotechnology Value Fund, L.P. | 137.59K | 10.40% |
| 2024-05-17 | BVF II GP LLC | 107.26K | 8.10% |
| 2024-05-17 | BVF GP Holdings LLC | 244.86K | 18.50% |
| 2024-05-17 | Biotechnology Value Trading Fund OS LP | 9312.0 | 1.00% |
| 2024-05-17 | BVF Partners OS Ltd. | 9312.0 | 1.00% |
| 2024-05-17 | BVF GP Holdings LLC | 244.86K | 18.50% |
| 2024-05-17 | BVF Inc. | 257.62K | 19.50% |
| 2024-05-17 | Mark N. Lampert | 257.62K | 19.50% |
| 2024-05-17 | Biotechnology Value Trading Fund OS LP | 9312.0 | 1.00% |
| 2024-05-17 | BVF II GP LLC | 107.26K | 8.10% |
| 2024-05-17 | Biotechnology Value Trading Fund OS LP | 9312.0 | 1.00% |
| 2024-05-17 | BVF Inc. | 257.62K | 19.50% |
| 2023-06-12 | Sam Huang | 4.94M | 6.00% |
| 2023-06-12 | Checkpoint Capital (Master) Fund, LP | 4.94M | 6.00% |
| 2023-06-12 | Checkpoint Capital, LP | 4.94M | 6.00% |
| 2023-06-12 | Sam Huang | 4.94M | 6.00% |
| 2023-06-12 | Checkpoint Capital (Master) Fund, LP | 4.94M | 6.00% |
| 2023-06-12 | Checkpoint Capital, LP | 4.94M | 6.00% |
| 2023-05-22 | BVF Partners OS Ltd. | 744.97K | 1.00% |
| 2023-05-22 | BVF Partners L.P. | 20.61M | 22.00% |
| 2023-05-22 | Biotechnology Value Trading Fund OS LP | 744.97K | 1.00% |
| 2023-05-22 | Biotechnology Value Fund, L.P. | 11.01M | 11.80% |
| 2023-05-22 | BVF I GP LLC | 11.01M | 11.80% |
| 2023-05-22 | Biotechnology Value Fund II, L.P. | 8.58M | 9.20% |
| 2023-05-22 | BVF II GP LLC | 8.58M | 9.20% |
| 2023-05-22 | Biotechnology Value Fund, L.P. | 11.01M | 11.80% |
| 2023-05-22 | BVF I GP LLC | 11.01M | 11.80% |
| 2023-05-22 | Mark N. Lampert | 20.61M | 22.00% |
| 2023-05-22 | BVF Inc. | 20.61M | 22.00% |
| 2023-05-22 | Biotechnology Value Fund II, L.P. | 8.58M | 9.20% |
| 2023-05-22 | BVF II GP LLC | 8.58M | 9.20% |
| 2023-05-22 | Biotechnology Value Trading Fund OS LP | 744.97K | 1.00% |
| 2023-05-22 | BVF Partners OS Ltd. | 744.97K | 1.00% |
| 2023-05-22 | BVF GP Holdings LLC | 19.59M | 20.90% |
| 2023-05-22 | BVF Partners L.P. | 20.61M | 22.00% |
| 2023-05-22 | BVF Inc. | 20.61M | 22.00% |
| 2023-05-22 | Mark N. Lampert | 20.61M | 22.00% |
| 2023-05-22 | BVF GP Holdings LLC | 19.59M | 20.90% |
| 2023-01-27 | Master Fund, L.P. | 4M | 5.40% |
| 2023-01-27 | Master Fund, L.P. | 4M | 5.40% |
| 2023-01-27 | Levy | 4M | 5.40% |
| 2023-01-27 | Group, LLC | 4M | 5.40% |
| 2023-01-27 | LLC | 4M | 5.40% |
| 2023-01-27 | Levy | 4M | 5.40% |
| 2023-01-27 | Group, LLC | 4M | 5.40% |
| 2023-01-27 | LLC | 4M | 5.40% |
| 2022-10-24 | Lynx1 Capital Management LP | 3.82M | 5.10% |
| 2022-10-24 | Weston Nichols | 3.82M | 5.10% |
| 2022-10-24 | Lynx1 Capital Management LP | 3.82M | 5.10% |
| 2022-10-24 | Weston Nichols | 3.82M | 5.10% |
| 2022-01-27 | LLC | 3.88M | 5.40% |
| 2022-01-27 | Master Fund, L.P. | 3.88M | 5.40% |
| 2022-01-27 | Master Fund, L.P. | 3.88M | 5.40% |
| 2022-01-27 | LLC | 3.88M | 5.40% |
| 2022-01-27 | Group, LLC | 3.88M | 5.40% |
| 2022-01-27 | Levy | 3.88M | 5.40% |
| 2022-01-27 | Group, LLC | 3.88M | 5.40% |
| 2022-01-27 | Levy | 3.88M | 5.40% |
| 2021-07-06 | 2. | 10.0 | 0.30% |
| 2021-07-06 | 2. | 10.0 | 4.90% |
| 2021-07-06 | Citadel Advisors Holdings LP | 6.0 | 4.90% |
| 2021-07-06 | 2. | 10.0 | 4.90% |
| 2021-07-06 | 2. | 10.0 | 0.30% |
| 2021-07-06 | 2. | 10.0 | 5.20% |
| 2021-07-06 | 2. | 10.0 | 0.30% |
| 2021-07-06 | 2. | 10.0 | 4.90% |
| 2021-04-08 | AstraZeneca PLC | 1.0 | 2.00% |
| 2021-04-02 | Seagen Inc. | 3.71M | 6.20% |
| 2021-02-16 | 5 G.P. L.P. | 3.57M | 6.40% |
| 2021-02-16 | Management 4 G.P. Ltd. | 3.57M | 6.40% |
| 2021-02-16 | Kariv | 3.57M | 6.40% |
| 2021-02-16 | Management 4 G.P. Ltd. | 3.57M | 6.40% |
| 2021-02-16 | Nussbaum | 3.57M | 6.40% |
| 2021-02-16 | Kariv | 3.57M | 6.40% |
| 2021-02-16 | 5 G.P. L.P. | 3.57M | 6.40% |
| 2021-02-16 | Nussbaum | 3.57M | 6.40% |
| 2020-02-07 | (1) BlackRock, Inc. | 3.41M | 6.20% |
| 2019-11-14 | EcoR1 Capital, LLC | 5.07M | 11.00% |
| 2019-11-14 | Oleg Nodelman | 5.07M | 11.00% |
| 2019-11-14 | EcoR1 Capital Fund Qualified, L.P. | 4.22M | 11.00% |
| 2019-11-14 | EcoR1 Capital, LLC | 5.07M | 11.00% |
| 2019-11-14 | Oleg Nodelman | 5.07M | 11.00% |
| 2019-11-14 | EcoR1 Capital Fund Qualified, L.P. | 4.22M | 11.00% |
| 2019-10-07 | Aquilo Capital, L.P. | 2.5M | 5.10% |
| 2019-10-07 | Aquilo Capital, L.P. | 2.5M | 5.10% |
| 2019-10-07 | Aquilo Capital Management, LLC | 2.9M | 5.90% |
| 2019-10-07 | Mr. Marc Schneidman | 2.9M | 5.90% |
| 2019-10-07 | Aquilo Capital Management, LLC | 2.9M | 5.90% |
| 2019-10-07 | Mr. Marc Schneidman | 2.9M | 5.90% |
| 2017-02-14 | Lombard Odier Asset Management (USA) Corp | 2.42M | 5.63% |
| 2016-06-17 | BVF Partners OS Ltd. | 419K | 1.00% |
| 2016-06-17 | Biotechnology Value Trading Fund OS LP | 419K | 1.00% |
| 2016-06-17 | Biotechnology Value Fund II, L.P. | 1.4M | 2.90% |
| 2016-06-17 | Biotechnology Value Fund, L.P. | 1.95M | 4.10% |
| 2016-06-17 | BVF Partners L.P. | 4.78M | 9.99% |
| 2016-06-17 | Biotechnology Value Trading Fund OS LP | 419K | 1.00% |
| 2016-06-17 | Mark N. Lampert | 4.78M | 9.99% |
| 2016-06-17 | BVF Inc. | 4.78M | 9.99% |
| 2016-06-17 | Mark N. Lampert | 4.78M | 9.99% |
| 2016-06-17 | Biotechnology Value Fund, L.P. | 1.95M | 4.10% |
| 2016-06-17 | Biotechnology Value Fund II, L.P. | 1.4M | 2.90% |
| 2016-06-17 | BVF Partners OS Ltd. | 419K | 1.00% |
| 2016-06-17 | BVF Partners L.P. | 4.78M | 9.99% |
| 2016-06-17 | BVF Inc. | 4.78M | 9.99% |
| 2016-02-16 | Lombard Odier Asset Management (USA) Corp | 2.85M | 7.17% |
| 2016-02-16 | Lombard Odier Asset Management (USA) Corp | 2.85M | 7.17% |
| 2015-09-11 | 6.25% (2) | 2.48M | 6.25% |
| 2015-09-11 | 6.25% (2) | 2.48M | 6.25% |
| 2015-09-11 | 6.25% (2) | 2.48M | 6.25% |
| 2015-09-11 | 6.25% (2) | 2.48M | 6.25% |
| 2015-09-11 | 6.25% (2) | 2.48M | 6.25% |
| 2015-09-11 | 6.25% (2) | 2.48M | 6.25% |
| 2015-09-11 | 6.25% (2) | 2.48M | 6.25% |
| 2015-07-10 | Mark N. Tompkins | 2.18M | 5.60% |
| 2015-07-09 | Samuel D. Isaly | 7.26M | 18.80% |
| 2015-07-09 | OrbiMed Capital GP III LLC | 7.19M | 18.70% |
| 2015-07-09 | OrbiMed Advisors LLC | 7.26M | 18.80% |
PVLA Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $104.67 | 11.25M | $1.18B | $57.98M | $633K | $1.12B |
| 2024-12-31 | $12.00 | 2.23M | $26.71M | $83.6M | -$ | -$56.89M |
| 2023-12-31 | $17.00 | 1.27M | $21.56M | $7.35M | -$ | $14.21M |
| 2022-12-31 | $17.00 | 930.35K | $15.82M | $16.05M | -$ | -$237.02K |
| 2021-12-31 | $17.00 | 806.84K | $13.72M | $117.76M | $14.89M | -$89.16M |
| 2020-12-31 | $17.00 | - | -$ | $70.44M | $16.96M | -$53.47M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $124.65 | 13.09M | $1.63B | $206.39M | $584K | $1.43B |
| 2025-12-31 | $104.67 | 11.25M | $1.18B | $57.98M | $633K | $1.12B |
| 2025-09-30 | $62.69 | 11.06M | $693.62M | $63.57M | $16.02M | $646.07M |
| 2025-06-30 | $22.54 | 11.05M | $249.13M | $70.43M | $14.51M | $193.21M |
| 2025-03-31 | $27.99 | 2.23M | $62.31M | $75.63M | -$ | -$13.32M |
| 2024-12-31 | $12.00 | 2.23M | $26.71M | $83.6M | -$ | -$56.89M |
| 2024-09-30 | $17.00 | 1.32M | $22.44M | $19.36M | -$ | $3.08M |
| 2024-06-30 | $17.00 | 1.29M | $22M | $19.73M | -$ | $2.27M |
| 2024-03-31 | $17.00 | 1.27M | $21.56M | $6.25M | -$ | $15.31M |
| 2023-12-31 | $17.00 | 1.24M | $21.03M | $17.4M | -$ | $3.63M |
| 2023-09-30 | $17.00 | 1.24M | $21.01M | $32.89M | $12.29M | $410K |
| 2023-06-30 | $17.00 | 1.1M | $18.62M | -$ | -$ | $18.62M |